Tyler Zeronda
Direttore Finanziario/CFO presso VYNE THERAPEUTICS INC.
Patrimonio netto: 325 405 $ in data 30/04/2024
Posizioni attive di Tyler Zeronda
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VYNE THERAPEUTICS INC. | Direttore Finanziario/CFO | 18/06/2021 | - |
| Treasurer | 18/06/2021 | - |
Storia della carriera di Tyler Zeronda
Precedenti posizioni note di Tyler Zeronda
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | - | - |
Formazione di Tyler Zeronda
| University of Virginia | Graduate Degree |
| Lafayette College | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Director of Finance/CFO | 2 |
| Treasurer | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VYNE THERAPEUTICS INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Borsa valori
- Insiders
- Tyler Zeronda
- Esperienza